Literature DB >> 6130958

Effects of putative dopamine autoreceptor agonists in pharmacological models related to dopaminergic and neuroleptic activity.

J Arnt, A V Christensen, J Hyttel, J J Larsen, O Svendsen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6130958     DOI： 10.1016/0014-2999(82)90316-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN： 0014-2999            Impact factor:   4.432


× No keyword cloud information.
  10 in total

1.  (+)-UH 232 and (+)-UH 242: novel stereoselective dopamine receptor antagonists with preferential action on autoreceptors.

Authors:  K Svensson; S Hjorth; D Clark; A Carlsson; H Wikström; B Andersson; D Sanchez; A M Johansson; L E Arvidsson; U Hacksell
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

Review 2.  Dopamine-receptor agonists: mechanisms underlying autoreceptor selectivity. I. Review of the evidence.

Authors:  D Clark; S Hjorth; A Carlsson
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

3.  Pharmacologic properties of (-)-3PPP (preclamol) in man.

Authors:  C A Tamminga; N G Cascella; R A Lahti; M Lindberg; A Carlsson
Journal:  J Neural Transm Gen Sect       Date:  1992

4.  Dopamine receptor agonists: intrinsic activity vs. state of receptor.

Authors:  A Carlsson
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

5.  Central dopamine receptor agonist and antagonist actions of the enantiomers of 3-PPP.

Authors:  S Hjorth; A Carlsson; D Clark; K Svensson; H Wikström; D Sanchez; P Lindberg; U Hacksell; L E Arvidsson; A Johansson
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

6.  Postsynaptic dopamine agonistic effects of 3-PPP enantiomers revealed by bilateral 6-hydroxy-dopamine lesions and by chronic reserpine treatment in rats.

Authors:  J Arnt; J Hyttel
Journal:  J Neural Transm       Date:  1984       Impact factor: 3.575

7.  Dopamine receptor agonistic and antagonistic effects of 3-PPP enantiomers.

Authors:  J Arnt; K P Bøgesø; A V Christensen; J Hyttel; J J Larsen; O Svendsen
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

8.  In vitro effect of the racemic mixture and the (-)enantiomer of N-n-propyl-3-(3-hydroxyphenyl)-piperidine (3-PPP) on postsynaptic dopamine receptors and on a presynaptic dopamine autoreceptor.

Authors:  R Markstein; D Lahaye
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

9.  An electrophysiological analysis of the actions of the 3-PPP enantiomers on the nigrostriatal dopamine system.

Authors:  D Clark; G Engberg; E Pileblad; T H Svensson; A Carlsson; A S Freeman; B S Bunney
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-06       Impact factor: 3.000

10.  Sub-chronic administration of (-)-3-PPP and central dopamine receptor sensitivity changes.

Authors:  S Hjorth; D Clark; K Svensson; A Carlsson; O Thorberg
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.